UNICYCIVE THERAPEUTICS, INC. Dividends, Preferred Stock, Cash
UNICYCIVE THERAPEUTICS, INC. (UNCY) reported Dividends, Preferred Stock, Cash of $72.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Shareholders' Equity
us-gaap:DividendsPreferredStockCash · last filed 2024-11-13
- UNICYCIVE THERAPEUTICS, INC. dividends, preferred stock, cash for the quarter ending 2023-09-30 was $72.00K.
- UNICYCIVE THERAPEUTICS, INC. dividends, preferred stock, cash for the quarter ending 2023-06-30 was $603.00K.
| Period end | Dividends, Preferred Stock, Cash 3 month | Dividends, Preferred Stock, Cash 6 month | Dividends, Preferred Stock, Cash 9 month |
|---|---|---|---|
| 2023-09-30 | $72.00K 10-Q · filed 2024-11-13 | $675.00K derived: sum of 2 quarters · filed 2024-11-13 | $867.00K 10-Q · filed 2024-11-13 |
| 2023-06-30 | $603.00K 10-Q · filed 2023-08-14 | $795.00K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |